A 50-Year-Old Female with Recurrent Stroke-Like Episodes and A Diagnosis of Systemic Lupus Erythematosus

Authors

  • S. V. Sathyapriya
  • M Bhavana Reddy
  • V. Padma
  • Sharath Chandra Reddy
  • Veera Vignesh

DOI:

https://doi.org/10.52783/jns.v14.2418

Keywords:

Stroke, Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Recurrent Ischemic Stroke

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder that can present with neurological manifestations, including stroke. Antiphospholipid syndrome (APS), a common complication of SLE, increases the risk of recurrent thrombotic events. We report a 50-year-old female with hypertension and diabetes who initially presented with acute left-sided hemiparesis and was diagnosed with an ischemic stroke in the right middle cerebral artery (MCA) territory. She was treated with dual antiplatelet therapy and statins, leading to partial recovery. Two weeks later, she developed worsening left-sided weakness progressing to hemiplegia, with MRI showing new infarcts. A hypercoagulability workup revealed positive lupus anticoagulant, anticardiolipin antibodies, and anti-β2 glycoprotein I antibodies, confirming APS. Further testing for autoimmune disorders showed positive ANA and anti-dsDNA, leading to a diagnosis of SLE. The patient was started on anticoagulation, hydroxychloroquine, and corticosteroids, resulting in clinical improvement. This case highlights the importance of considering SLE and APS in patients with recurrent strokes, as early diagnosis and appropriate treatment can significantly reduce morbidity and prevent further thrombotic events.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Hanly JG, Urowitz MB, Su L, et al. Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of the Hopkins Lupus Cohort. Arthritis Rheum. 2010;62(3):773-782.

Tektonidou MG. Neurologic manifestations of antiphospholipid syndrome: insights from pathogenic mechanisms to therapeutic approaches. Front Immunol. 2018;9:1141.

Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019-1027.

Sanna G, Bertolaccini ML, Mathieu A, et al. Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Lupus. 2003;12(12):908-911.

Bertsias GK, Ioannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR Standing Committee for Clinical Affairs. Ann Rheum Dis. 2010;69(12):2074-2082.

Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498-1509.

Downloads

Published

2025-03-21

How to Cite

1.
Sathyapriya SV, Reddy MB, Padma V, Reddy SC, Vignesh V. A 50-Year-Old Female with Recurrent Stroke-Like Episodes and A Diagnosis of Systemic Lupus Erythematosus. J Neonatal Surg [Internet]. 2025Mar.21 [cited 2025Sep.20];14(7S):378-9. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/2418